Results 61 to 70 of about 1,439 (152)

Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections

Infectious Diseases and Therapy, 2019
Introduction Dalbavancin is approved for acute bacterial skin and skin structure infections (ABSSSIs) but offers a potential treatment option for complicated invasive gram-positive infections.
Jacqueline T. Bork, Emily L. Heil, Shanna Berry, Eurides Lopes, Rohini Davé, Bruce L. Gilliam, Anthony Amoroso   +6 more
doaj   +1 more source

A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections

Infectious Diseases and Therapy, 2020
Background We sought to determine the real-world incidence of and risk factors for vancomycin-associated acute kidney injury (V-AKI) in hospitalized adults with acute bacterial skin and skin structure infections (ABSSSI).
Sarah C. J. Jorgensen, Kyle P. Murray, Abdalhamid M. Lagnf, Sarah Melvin, Sahil Bhatia, Muhammad-Daniayl Shamim, Jordan R. Smith, Karrine D. Brade, Samuel P. Simon, Jerod Nagel, Karen S. Williams, Jessica K. Ortwine, Michael P. Veve, James Truong, David B. Huang, Susan L. Davis, Michael J. Rybak   +16 more
doaj   +1 more source

Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection/acute bacterial skin and skin structure infection – issues and therapeutic options

, 2023
Purpose of review This review comments on the current guidelines for the treatment of wound infections under definition of acute bacterial skin and skin structure infections (ABSSSI).
Becker, Karsten, Thalhammer, Florian, Sunderkötter, Cord, Hanses, Frank, Eckmann, Christian, Grabein, Béatrice, Wichmann, Dominic, Hagel, Stefan   +7 more
core   +1 more source

Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019

Journal of Global Antimicrobial Resistance, 2021
: Objectives: Omadacycline was tested against 7000 bacterial isolates collected prospectively from medical centres in the USA during 2019. Methods: Antimicrobial susceptibility testing was performed according to Clinical and Laboratory Standards ...
Michael A. Pfaller, Michael D. Huband, Dee Shortridge, Robert K. Flamm   +3 more
doaj   +1 more source

Dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients: a case series

Acute bacterial skin and skin-structure infections (ABSSSI) are a significant cause of morbidity in pediatric patients, requiring timely and effective treatment.
Polara, Valentina Frasca, Macaluso, Alessandra, Parrino, Roberta, Venuti, Laura, Condemi, Anna, Colomba, Claudia, Garbo, Valeria, Albano, Chiara   +7 more
core   +1 more source

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Patients with Diabetes Mellitus

, 2017
Background ABSSSIs are common in patients with diabetes and have an increased risk of complications. Dalbavancin is a long-acting lipoglycopeptide with potent activity against Gram-positive pathogens responsible for ABSSSI, including ...
Urania Rappo, David Talan, Jason Bryowsky, Jennifer S McGregor, Pedro L Gonzalez, Jie Chen, Michael Nowak   +6 more
core   +1 more source

Acute Bacterial Skin Infections: Developments Since the 2005 Infectious Diseases Society of America (IDSA) Guidelines [PDF]

, 2013
BackgroundPatients with acute bacterial skin and skin structure infections (ABSSSI) commonly present to Emergency Departments (EDs) where physicians encounter a wide spectrum of disease severity. The prevalence of community-acquired methicillin-resistant
Abrahamian, Fredrick M., Moran, Gregory J., Talan, David A., LoVecchio, Frank   +3 more
core   +1 more source

Examination of hospital length of stay in Canada among patients with acute bacterial skin and skin structure infection caused by methicillin-resistant Staphylococcus aureus

Infection and Drug Resistance, 2016
Michele H Potashman,1 Michael Stokes,2 Jieruo Liu,2 Robin Lawrence,1 Linda Harris1 1Global Health Outcomes, Merck & Co, Inc., Kenilworth, NJ, USA; 2Evidera, Lexington, MA, USA Purpose: Skin infections, particularly those caused by resistant ...
Potashman MH, Stokes M, Liu J, Lawrence R, Harris L   +4 more
doaj  

Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey

, 2018
To explore the attitudes of European physicians on adherence and how treatment modalities impact adherence in complicated forms of soft skin and skin structure infections, now referred as acute bacterial skin and skin structures infections (ABSSSI ...
Emilio Bouza, Gian Maria Rossolini, Tom Stargardt, Paolo Antonio Grossi, Stargardt, Tom, Eckmann, Christian, Grossi, Paolo Antonio, Bouza, Emilio, Christian Eckmann, Rossolini, Gian Maria   +9 more
core   +1 more source

Analisi preliminare sull’impatto clinico-organizzativo della gestione delle ABSSSI: focus sui criteri di dimissione precoce

, 2019
INTRODUZIONE: Le Acute Bacterial Skin and Skin Structure Infections (ABSSSI) sono patologie eterogenee, solitamente di modesta gravità. Possono tuttavia manifestarsi con quadri clinici più severi, pertanto la gestione può risultare complessa, con ...
G. Zanelli, F. Montagnani, S. Modica, C. Cassol, G. Stella, D. Marri, L. Migliorini, B. Rossetti   +7 more
core   +1 more source